Skip to content
Catalyst

Salvia miltiorrhizaFinding

Salvia miltiorrhiza decreases malondialdehyde (circulating)

lowersVery limited evidenceFinding

01 · The sentence it was drawn from

“Overall, the malondialdehyde (MDA) level at day 30 in the treatment group was significantly lower than in the placebo group.”
Quoted verbatim from Effect of Salvia miltiorrhiza hydrophilic extract on antioxidant enzymes in diabetic patients with chronic heart disease: a randomized controlled trial.
This finding among the 39 findings on its endpoint

Salvia miltiorrhiza

Malondialdehyde (circulating)

lowers

Who
Diabetic patients with chronic heart disease; hypoglycemic therapy given to both arms, hydrophilic extract added in the treatment arm; day 30 timepoint only
Dose studied
dose and route of administration not stated in the abstract, given on top of hypoglycemic therapy

Very limited evidencePMID 21544882 · 2012

02 · The study

Study
RCT
Duration
4 weeks

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7F418ZVS2A92QKWYV8WQGAA